Profits have risen at British pharmaceutical company AstraZeneca, leading to an improved forecast for the year as a whole.
"We are grateful to our associates, partners, and customers who supported our return to the public markets in October, building upon our 45-year legacy of powering the world’s leading technology ...
Q3 2024 Earnings Call Transcript November 7, 2024 BlackLine, Inc. beats earnings expectations. Reported EPS is $0.6, ...
Q2 2025 Earnings Call Transcript November 4, 2024 8×8, Inc. beats earnings expectations. Reported EPS is $0.09, expectations ...
Benchmark Electronics, Inc. beats earnings expectations. Reported EPS is $0.57, expectations were $0.54. Operator: Good day, ...
Achieves 10% year-over-year revenue growth, record GAAP net income of $27.8 million and adjusted EBITDA of $43.2 millionThird-quarter GAAP ...
Revenue of $12.0 millionTotal Contract Value (“TCV”)(1) bookings of $8.8 millionGross margin of 58%Adjusted EBITDA(1) loss of $0.6 millionEPS ...
GE HealthCare Technologies gets a buy rating, agreeing with today's Wall Street and SA analyst consensus. Explore more ...
Q3 2024 Results Conference Call November 6, 2024 4:30 PM ETCompany ParticipantsWinnie Ling - Head-Legal and PeopleNima ...
Italy's Mediobanca posted a better-than-expected quarterly profit on Tuesday as net fees more than offset a small decline in ...